A prospective, phase 4, single arm clinical study to evaluate the effects of bazedoxifene on volumetric bone mineral density, bone architecture and derived strength in women with postmenopausal osteoporosis.

Trial Profile

A prospective, phase 4, single arm clinical study to evaluate the effects of bazedoxifene on volumetric bone mineral density, bone architecture and derived strength in women with postmenopausal osteoporosis.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 May 2016

At a glance

  • Drugs Bazedoxifene (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Acronyms Tibia Pqct Study
  • Most Recent Events

    • 12 May 2016 Status changed from discontinued to recruiting.
    • 12 May 2016 Status changed from recruiting to discontinued.
    • 17 Apr 2016 Results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top